Investigation of Lupeol as Anti-Melanoma Agent: An In Vitro-In Ovo Perspective
Malignant melanoma (MM) represents the most life-threatening skin cancer worldwide, with a narrow and inefficient chemotherapeutic arsenal available in advanced disease stages. Lupeol (LUP) is a triterpenoid-type phytochemical possessing a broad spectrum of pharmacological properties, including a po...
Main Authors: | Flavia Bociort, Ioana Gabriela Macasoi, Iasmina Marcovici, Andrei Motoc, Cristina Grosu, Iulia Pinzaru, Crina Petean, Stefana Avram, Cristina Adriana Dehelean |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/6/425 |
Similar Items
-
Detection of Lupeol in Calendula Officinalis Grown in Iraq by GC-MS Analysis
by: Noor Ali Kadhim, et al.
Published: (2019-12-01) -
Oleogel Formulations for the Topical Delivery of Betulin and Lupeol in Skin Injuries—Preparation, Physicochemical Characterization, and Pharmaco-Toxicological Evaluation
by: Ramona Daniela Pârvănescu (Pană), et al.
Published: (2021-07-01) -
Lupeol Accumulation Correlates with Auxin in the Epidermis of Castor
by: Donghai Li, et al.
Published: (2021-05-01) -
In-depth analysis of lupeol: delving into the diverse pharmacological profile
by: Aminah Dalimunthe, et al.
Published: (2024-11-01) -
Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes
by: Vaithinathan Selvaraju, et al.
Published: (2025-01-01)